EyenovIA, Inc. Files 2024 Annual Report Amendment
Ticker: HYPD · Form: 10-K/A · Filed: Apr 30, 2025 · CIK: 1682639
| Field | Detail |
|---|---|
| Company | Eyenovia, INC. (HYPD) |
| Form Type | 10-K/A |
| Filed Date | Apr 30, 2025 |
| Risk Level | medium |
| Sentiment | neutral |
Sentiment: neutral
Topics: amendment, annual-report, pharmaceuticals
TL;DR
EYEN filed its 2024 10-K amendment today. Check for updates.
AI Summary
EyenovIA, Inc. filed an amendment (10-K/A) to its annual report for the fiscal year ended December 31, 2024. The company, headquartered in New York, NY, is in the pharmaceutical preparations industry. This filing provides updated information for the period ending December 31, 2024, with the amendment filed on April 30, 2025.
Why It Matters
This amendment to EyenovIA's 10-K provides updated financial and operational details for the fiscal year 2024, which is crucial for investors to assess the company's performance and future outlook.
Risk Assessment
Risk Level: medium — As a pharmaceutical company, EyenovIA faces inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024 — Fiscal Year End (The period covered by the annual report.)
- 10-K/A — Filing Type (Indicates an amendment to the annual report.)
- 001-38365 — SEC File Number (Unique identifier for the company's filings.)
Key Players & Entities
- EYENOVIA, INC. (company) — Registrant
- 20241231 (date) — Fiscal year end
- 20250430 (date) — Filing date of amendment
- New York, NY (location) — Company headquarters
- 2834 (industry_code) — Standard Industrial Classification for Pharmaceutical Preparations
FAQ
What specific information was updated in this 10-K/A filing?
The filing is an amendment to the annual report for the fiscal year ended December 31, 2024, indicating updates to previously filed information, though the specific details of the amendments are not provided in this header.
When was the original 10-K filed, and what is the significance of this amendment?
The original 10-K was for the fiscal year ended December 31, 2024. This amendment (10-K/A) was filed on April 30, 2025, to correct or supplement information in the original filing.
What industry is EyenovIA, Inc. in?
EyenovIA, Inc. is in the Pharmaceutical Preparations industry, with a Standard Industrial Classification code of 2834.
Where is EyenovIA, Inc. headquartered?
EyenovIA, Inc. is headquartered at 295 Madison Avenue, Suite 2400, New York, NY 10017.
What is the SEC file number for EyenovIA, Inc.?
The SEC file number for EyenovIA, Inc. is 001-38365.
Filing Details
This Form 10-K/A (Form 10-K/A) was filed with the SEC on April 30, 2025 regarding EYENOVIA, INC. (HYPD).